Literature DB >> 32959116

Submucosal lifting agent ORISE gel causes extensive foreign body granuloma post endoscopic resection.

Belinda L Sun1.   

Abstract

BACKGROUND: Submucosal injection of lifting solution is often performed to facilitate endoscopic mucosal resection or endoscopic submucosal dissection. ORISETM gel is a synthetic solution recently approved by the US Food and Drug Administration (FDA) in 2018 for use as submucosal lifting solution for endoscopic resection procedures and has gained popularity for its convenient pre-filled syringe. However, here the present two cases show that ORISETM gel induces marked foreign body giant cell granulomatous reaction in the submucosa and muscularis propria following endoscopic resection. METHODS AND
RESULTS: A 73-year-old female underwent laparoscopic right colectomy after her initial endoscopic polypectomy of a hyperplastic polyp, and a 78-year-old male had partial gastrectomy following endoscopic mucosal resection of an invasive adenocarcinoma. Both patients had submucosal injection of ORISETM gel during endoscopic procedures, and the surgical resection specimens showed ORISETM gel deposition and extensive foreign body giant cell granulomatous reaction in the submucosa and muscularis propria.
CONCLUSION: These cases raise the awareness that ORISETM gel stimulates extensive foreign body reaction at the injection site, and the further consequence is still unclear.

Entities:  

Keywords:  Endoscopic resection; Foreign body giant cell reaction; Lifting solution; ORISETM gel; Submucosal injection

Mesh:

Year:  2020        PMID: 32959116     DOI: 10.1007/s00384-020-03764-y

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  4 in total

Review 1.  Foreign body reaction to biomaterials.

Authors:  James M Anderson; Analiz Rodriguez; David T Chang
Journal:  Semin Immunol       Date:  2007-12-26       Impact factor: 11.130

2.  Features of endoscopic procedure site reaction associated with a recently approved submucosal lifting agent.

Authors:  Carlos A Castrodad-Rodríguez; Nicole C Panarelli; Adam J Gersten; Qiang Liu; Michael Feely; Tony El Jabbour
Journal:  Mod Pathol       Date:  2020-03-02       Impact factor: 7.842

3.  Endoscopic Removal of Colorectal Lesions-Recommendations by the US Multi-Society Task Force on Colorectal Cancer.

Authors:  Tonya Kaltenbach; Joseph C Anderson; Carol A Burke; Jason A Dominitz; Samir Gupta; David Lieberman; Douglas J Robertson; Aasma Shaukat; Sapna Syngal; Douglas K Rex
Journal:  Gastroenterology       Date:  2020-02-11       Impact factor: 22.682

Review 4.  Submucosal injection solution for endoscopic resection in gastrointestinal tract: a traditional and network meta-analysis.

Authors:  Zhang Yu Huai; Wei Feng Xian; Luo Chang Jiang; Wang Xi Chen
Journal:  Gastroenterol Res Pract       Date:  2015-01-29       Impact factor: 2.260

  4 in total
  1 in total

1.  Potential clinical complications of Orise™ gel use, a new submucosal lifting agent: experience from a tertiary care center and review of the literature.

Authors:  Yasar Colak; Badar Hasan; Kanwarpreet Tandon; Sikandar Khan; Vaibhav Wadhwa; Pablo A Bejarano; Tolga Erim
Journal:  Ann Gastroenterol       Date:  2022-06-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.